Fowkes Freya J I, Allen Stephen J, Allen Angela, Alpers Michael P, Weatherall David J, Day Karen P
Peter Medawar Building for Pathogen Research and Department of Zoology, University of Oxford, Oxford, United Kingdom.
PLoS Med. 2008 Mar 18;5(3):e56. doi: 10.1371/journal.pmed.0050056.
The heritable haemoglobinopathy alpha(+)-thalassaemia is caused by the reduced synthesis of alpha-globin chains that form part of normal adult haemoglobin (Hb). Individuals homozygous for alpha(+)-thalassaemia have microcytosis and an increased erythrocyte count. Alpha(+)-thalassaemia homozygosity confers considerable protection against severe malaria, including severe malarial anaemia (SMA) (Hb concentration < 50 g/l), but does not influence parasite count. We tested the hypothesis that the erythrocyte indices associated with alpha(+)-thalassaemia homozygosity provide a haematological benefit during acute malaria.
Data from children living on the north coast of Papua New Guinea who had participated in a case-control study of the protection afforded by alpha(+)-thalassaemia against severe malaria were reanalysed to assess the genotype-specific reduction in erythrocyte count and Hb levels associated with acute malarial disease. We observed a reduction in median erythrocyte count of approximately 1.5 x 10(12)/l in all children with acute falciparum malaria relative to values in community children (p < 0.001). We developed a simple mathematical model of the linear relationship between Hb concentration and erythrocyte count. This model predicted that children homozygous for alpha(+)-thalassaemia lose less Hb than children of normal genotype for a reduction in erythrocyte count of >1.1 x 10(12)/l as a result of the reduced mean cell Hb in homozygous alpha(+)-thalassaemia. In addition, children homozygous for alpha(+)-thalassaemia require a 10% greater reduction in erythrocyte count than children of normal genotype (p = 0.02) for Hb concentration to fall to 50 g/l, the cutoff for SMA. We estimated that the haematological profile in children homozygous for alpha(+)-thalassaemia reduces the risk of SMA during acute malaria compared to children of normal genotype (relative risk 0.52; 95% confidence interval [CI] 0.24-1.12, p = 0.09).
The increased erythrocyte count and microcytosis in children homozygous for alpha(+)-thalassaemia may contribute substantially to their protection against SMA. A lower concentration of Hb per erythrocyte and a larger population of erythrocytes may be a biologically advantageous strategy against the significant reduction in erythrocyte count that occurs during acute infection with the malaria parasite Plasmodium falciparum. This haematological profile may reduce the risk of anaemia by other Plasmodium species, as well as other causes of anaemia. Other host polymorphisms that induce an increased erythrocyte count and microcytosis may confer a similar advantage.
遗传性血红蛋白病α(+)-地中海贫血是由构成正常成人血红蛋白(Hb)一部分的α-珠蛋白链合成减少所致。α(+)-地中海贫血纯合子个体有小红细胞症和红细胞计数增加。α(+)-地中海贫血纯合子可提供相当程度的保护,预防包括严重疟疾贫血(SMA)(血红蛋白浓度<50g/l)在内的严重疟疾,但不影响寄生虫计数。我们检验了这样一个假设,即与α(+)-地中海贫血纯合子相关的红细胞指数在急性疟疾期间提供血液学益处。
对来自巴布亚新几内亚北海岸参与α(+)-地中海贫血对严重疟疾保护作用病例对照研究的儿童数据进行重新分析,以评估与急性疟疾疾病相关的红细胞计数和血红蛋白水平的基因型特异性降低情况。我们观察到,所有患急性恶性疟原虫疟疾的儿童,其红细胞计数中位数相对于社区儿童的值减少了约1.5×10¹²/l(p<0.001)。我们建立了血红蛋白浓度与红细胞计数之间线性关系的简单数学模型。该模型预测,由于纯合子α(+)-地中海贫血平均红细胞血红蛋白降低,红细胞计数减少>1.1×10¹²/l时,α(+)-地中海贫血纯合子儿童比正常基因型儿童血红蛋白损失更少。此外,α(+)-地中海贫血纯合子儿童红细胞计数要比正常基因型儿童多降低10%(p = 0.02),血红蛋白浓度才会降至50g/l(SMA的临界值)。我们估计,与正常基因型儿童相比,α(+)-地中海贫血纯合子儿童的血液学特征降低了急性疟疾期间患SMA的风险(相对风险0.52;95%置信区间[CI]0.24 - 1.12,p = 0.09)。
α(+)-地中海贫血纯合子儿童红细胞计数增加和小红细胞症可能对其预防SMA有很大作用。每个红细胞中血红蛋白浓度较低以及红细胞数量较多,可能是一种生物学上有利的策略,可应对恶性疟原虫急性感染期间红细胞计数的显著减少。这种血液学特征可能降低其他疟原虫种类以及其他贫血原因导致贫血的风险。其他诱导红细胞计数增加和小红细胞症的宿主多态性可能具有类似优势。